University of California San Francisco
San Francisco, California, United States
Purpose
to test the potential efficacy for enhancing autophagy activation during Mycobacterium tuberculosis infection and to evaluate if the newly-discovered autophagy agonist, DMXAA, will promote Mycobacterium tuberculosis clearance and synergize with antibiotics to eradicate persistent Mycobacterium tuberculosis infections in vivo
Division
Global Health
Date
November 2014
Region Served
GLOBAL
Committed amount
$163,431
Grant topic
Discovery and Translational Sciences
Duration (months)
13
Grantee location
San Francisco, California, United States
Related work
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.